Review: Methylxanthines are not effective for acute exacerbations of chronic obstructive pulmonary disease: COMMENTARY

Niewoehner, Dennis E.
May 2004
ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p60
Academic Journal
It was not so long ago that most experts recommended theophylline as a first-line agent for treating both stable and exacerbated chronic obstructive pulmonary disease (COPD). Theophylline use increased dramatically during the 1970s, but then waned just as quickly during the 1990s. These rapid shifts in prescribing patterns were not strongly evidence-based because large multicenter trials to evaluate clinical outcomes were never done. New findings suggest that theophylline may possess anti-inflammatory effects at levels below those clinically used in the past Moreover, secondary results from 2 large trials of stable COPD show that theophylline may prevent severe COPD exacerbations when given long term. If these findings can be confirmed, theophylline might yet play an important role in the treatment of COPD, if not for treating exacerbations, then for their prevention.


Related Articles

  • The Usefulness of Theophylline in Nonasthmatic Airway Obstruction. Schmidt, R.; Altschuler, S. // Angiology;Nov1979, Vol. 30 Issue 11, p744 

    This study evaluated the effectiveness of oral bronchodilator therapy using theophylline in patients with nonreversible chronic obstructive pulmonary disease. Twelve chronic obstructive pulmonary disease patients were entered into a doubleblind crossover study using either active drug...

  • Pharmacological management--oral treatment. Currie, Graeme P.; Lee, Daniel K. C.; Lipworth, Brian J. // BMJ: British Medical Journal (International Edition);6/24/2006, Vol. 332 Issue 7556, p1497 

    The article looks at oral treatments of chronic obstructive pulmonary disease. The article discusses the clinical use of theophylline, its adverse effects, including hypokalemia and tachycardia, oral corticosteroids, corticosteroid induced osteoporosis, oxygen therapy, symptomatic peripheral...

  • Theophylline and gastric emptying in very low birthweight neonates: a randomised controlled trial. Gounaris, A.; Kokori, P.; Varchalama, L.; Konstandinidi, K.; Skouroliakou, M.; Alexiou, N.; Costalos, C. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2004, Vol. 89 Issue 4, pf297 

    Background: Theophylline treatment causes side effects such as tachycardia, hyperglycaemia, abdominal distension, and vomiting. The latter two are probably the result of delayed gastric evacuation. Objective: To study the effect of theophylline on gastric emptying time in preterm infants....

  • Qualitative assessment of attributes and ease of use of the ELLIPTATM dry powder inhaler for delivery of maintenance therapy for asthma and COPD. Svedsater, Henrik; Dale, Peter; Garrill, Karl; Walker, Richard; Woepse, Mark W. // BMC Pulmonary Medicine;2013, Vol. 13 Issue 1, p1 

    Background Medications for respiratory disorders including asthma and chronic obstructive pulmonary disease (COPD) are typically delivered to the lung by means of a handheld inhaler. Patient preference for and ability to use the inhaler may influence their adherence to maintenance therapy, and...

  • Pharma: Clinic Roundup.  // BioWorld Today;8/31/2012, Vol. 23 Issue 170, p8 

    The article reports on an announcement by Sosei Group Corp. that its QVA149 met the primary endpoint in its fifth Phase III trial for chronic obstructive pulmonary disease treatment.

  • Budesonide/Formoterol Pressurized Metered-Dose Inhaler. Lyseng-Williamson, Katherine A. // Drugs;2009, Vol. 69 Issue 11, p1459 

    The corticosteroid budesonide and the rapid-onset, long-acting β2-adrenoceptor agonist formoterol have been combined into a single pressurized metered-dose inhaler (pMDI) for use in patients with chronic obstructive pulmonary disease (COPD). Well designed 6- and 12-month clinical trials,...

  • CROMOLYN.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p284 

    The article presents information on cromolyn, a nasal decongestant used to prevent asthma attacks and reduce nasal allergic symptoms. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug with other drugs is also...

  • Salmeterol for Nocturnal Asthma Symptoms. Miller, Karl E. // American Family Physician;1/1/2000, Vol. 61 Issue 1, p203 

    Discusses the study `Salmeterol Vs. Theophylline. Sleep and Efficacy Outcomes in Patients With Nocturnal Asthma,' by L. Wiegand and colleagues published in the June 1999 issue of `Chest.'

  • Phenotype-guided treatment of COPD. Is it the future or the present? Miravitlles, Marc // Hot Topics in Respiratory Medicine;2012, Issue 22, p13 

    The term phenotype as applied to chronic obstructive pulmonary disease (COPD) is defined as "those attributes of the disease that, alone or combined, describe the differences in clinically meaningful parameters between individuals with COPD". Among those described, there are four that are...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics